Oncology Research Training for Surgeon-Scientists
Oncology Research Training for Surgeon-Scientists
批准号:
10553434
负责人:
Bernard Mark Evers
金额:
$27.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
未结题
起止时间:
2011-07-01 至 2028-06-30
中文摘要
项目总结
英文摘要
PROJECT SUMMARY
This application is a competitive renewal of Translational Oncology Research Training for Surgeon Scientists,
a transformative training program at the University of Kentucky (UK) designed for qualified trainees in the
surgical disciplines and with an interest in oncology research. The program addresses critical national
declines in the number of surgeon scientists engaged in cancer research through a two-year period of
intensive, interdisciplinary mentored research training to prepare trainees to become independent scientists
who are well prepared to incorporate state-of-the-art techniques learned during their training period into a
successful academic research career. Trainees (2 each year) typically enter the program following
completion of postgraduate year (PGY) 2 or 3 of their residency training or upon completion of the surgical
residency and select either the basic science option (Track 1) or the healthcare delivery research option
(Track 2). Opportunities in Track 1 span cell signaling, tumor biology, cancer progression and metastasis as
well as evolving areas such metabolomics, oncogenomics and epigenetics. Track 2, a proposed new program
component, provides training in cancer disparities, implementation science and population-level enquiry. In
addition to an intensive research experience, trainees complete a Master of Science or PhD degree in clinical
and translational sciences and supplement their coursework with further development through a combination
of formal courses and professional skills development workshops and seminars in such areas as responsible
conduct of research, reproducibility and manuscript and proposal development. Through regularly scheduled
seminars and lectures available through the Markey Cancer Center, their departments and prominent UK
centers, including the Center for Clinical and Translational Science, trainees engage in rich experiential and
didactic learning that prepares them as active contributors to the types of multidisciplinary teams that are
essential for the optimal treatment of the complex cancer patient. The requirement to successfully complete
either a master’s or PhD degree adds depth and breadth to this program of training, broadening exposure to
other UK scientists serving on thesis committees. The primary training faculty is composed of basic and
population scientists and clinician-scientists, all of whom work collaboratively across disciplines; each primary
faculty mentor is a recognized expert in his or her field and has a long record of research productivity in the
training of young investigators. A “pipeline” mentor development mechanism allows us to develop promising
early-career faculty members as mentors within our team-based mentoring approach. This program, which is
committed to fostering diversity in the community of surgeon scientists, including women and those from
underrepresented groups, has been highly successful in achieving its goals to address alarming declines in
the number of active surgeon-scientists conducting oncology research. As a training faculty, we are
passionate, motivated and committed to the training of future academic surgeons.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Oncogenic Drivers of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
乳房植入相关的间变性大细胞淋巴瘤的致癌驱动因素。
DOI:
10.1097/prs.0000000000006331
发表时间:
2020
期刊:
Plastic and reconstructive surgery
影响因子:
3.6
作者:
[DeCoster,RyanC, Rinker,BrianD, Butterfield,TimothyA, Vasconez,HenryC]
通讯作者:
Vasconez,HenryC
Management of double carotid blowout with definitive repair after temporizing stent graft placement.
DOI:
10.1016/j.jvscit.2022.08.011
发表时间:
2022-12
期刊:
JOURNAL OF VASCULAR SURGERY CASES INNOVATIONS AND TECHNIQUES
影响因子:
0.7
作者:
[Cocca, Alexandra T., Levy, Brittany E., Castle, Jennifer T., Wilt, Wesley S., Fleming, Mark D., Kejner, Alexandra E., Aouad, Rony K., Tyagi, Samuel C.]
通讯作者:
Tyagi, Samuel C.
DOI:
10.3390/cancers14205049
发表时间:
2022-10-15
期刊:
Cancers
影响因子:
5.2
作者:
[]
通讯作者:
Impact of the Affordable Care Act on Providing Equitable Healthcare Access for IBD in the Kentucky Appalachian Region.
《平价医疗法案》对肯塔基州阿巴拉契亚地区 IBD 提供公平医疗服务的影响。
DOI:
10.1097/dcr.0000000000002942
发表时间:
2023
期刊:
Diseases of the colon and rectum
影响因子:
3.9
作者:
[Castle,JenniferT, Levy,BrittanyE, Mangino,AnthonyA, McDonald,HannahG, McAtee,ErinE, Patel,JiteshA, Evers,BMark, Bhakta,AvinashS]
通讯作者:
Bhakta,AvinashS
DOI:
10.21037/abs-20-96
发表时间:
2021-01-01
期刊:
Annals of breast surgery : an open access journal to bridge breast surgeons across the world
影响因子:
--
作者:
[Lynch, Evan B, DeCoster, Ryan C, Clemens, Mark W]
通讯作者:
Clemens, Mark W
共 14 条
Targeting the Immunosuppressive Tumor Microenvironment for Colorectal Cancer Treatment
-
批准号:10748123
-
项目类别:
-
资助金额:$40.03万
-
财政年份:2023
-
负责人:Bernard Mark Evers
-
依托单位:
Appalachian Career Training in Oncology (ACTION) Program
-
批准号:10001327
-
项目类别:
-
资助金额:$45.04万
-
财政年份:2018
-
负责人:Bernard Mark Evers
-
依托单位:
Appalachian Career Training in Oncology (ACTION) Program
-
批准号:10245140
-
项目类别:
-
资助金额:$45.98万
-
财政年份:2018
-
负责人:Bernard Mark Evers
-
依托单位:
Appalachian Career Training in Oncology (ACTION) Program
-
批准号:10475257
-
项目类别:
-
资助金额:$45.98万
-
财政年份:2018
-
负责人:Bernard Mark Evers
-
依托单位:
Altered Lipid Metabolism as a Novel Target for Colon Cancer Treatment
-
批准号:10227741
-
项目类别:
-
资助金额:$42.53万
-
财政年份:2017
-
负责人:Bernard Mark Evers
-
依托单位:
Mechanisms regulating neurotensin secretion and function
-
批准号:9219942
-
项目类别:
-
资助金额:$44.02万
-
财政年份:2017
-
负责人:Bernard Mark Evers
-
依托单位:
Mechanisms Regulating Neurotensin Secretion and Function
-
批准号:10536470
-
项目类别:
-
资助金额:$66.97万
-
财政年份:2017
-
负责人:Bernard Mark Evers
-
依托单位:
Mechanisms Regulating Neurotensin Secretion and Function
-
批准号:10651886
-
项目类别:
-
资助金额:$66.97万
-
财政年份:2017
-
负责人:Bernard Mark Evers
-
依托单位:
Novel pRNA Nanoparticle Delivery as Directed Therapy for Colorectal Cancer Metastasis
-
批准号:9547788
-
项目类别:
-
资助金额:$28.04万
-
财政年份:2015
-
负责人:Bernard Mark Evers
-
依托单位:
Novel pRNA Nanoparticle Delivery as Directed Therapy for Colorectal Cancer Metastasis
-
批准号:9753735
-
项目类别:
-
资助金额:$27.2万
-
财政年份:2015
-
负责人:Bernard Mark Evers
-
依托单位:
Cancer specific and organ-avoiding RNA architectures for quantitative imaging
-
批准号:9208386
-
项目类别:
-
资助金额:$29.27万
-
财政年份:2014
-
负责人:Bernard Mark Evers
-
依托单位:
Cancer specific and organ-avoiding RNA architectures for quantitative imaging
-
批准号:8883529
-
项目类别:
-
资助金额:$5.13万
-
财政年份:2014
-
负责人:Bernard Mark Evers
-
依托单位:
Cancer specific and organ-avoiding RNA architectures for quantitative imaging
-
批准号:8773989
-
项目类别:
-
资助金额:$34.16万
-
财政年份:2014
-
负责人:Bernard Mark Evers
-
依托单位:
Cancer specific and organ-avoiding RNA architectures for quantitative imaging
-
批准号:9298655
-
项目类别:
-
资助金额:$31.64万
-
财政年份:2014
-
负责人:Bernard Mark Evers
-
依托单位:
Administration
-
批准号:10470101
-
项目类别:
-
资助金额:$21.65万
-
财政年份:2013
-
负责人:Bernard Mark Evers
-
依托单位:
Interdisciplinary Research Training in Cancer Biology
-
批准号:8475191
-
项目类别:
-
资助金额:$19.63万
-
财政年份:2013
-
负责人:Bernard Mark Evers
-
依托单位:
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
-
批准号:9275578
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2013
-
负责人:Bernard Mark Evers
-
依托单位:
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
-
批准号:9120005
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2013
-
负责人:Bernard Mark Evers
-
依托单位:
Leadership, Planning and Evaluation
-
批准号:10204900
-
项目类别:
-
资助金额:$23.67万
-
财政年份:2013
-
负责人:Bernard Mark Evers
-
依托单位:
Developmental Funds
-
批准号:10204899
-
项目类别:
-
资助金额:$27.97万
-
财政年份:2013
-
负责人:Bernard Mark Evers
-
依托单位:
海外基金